Nursing Home Residents Overlooked in Scramble for Covid Antibody Treatments

November 1, 2021

(Kaiser Health News) – Across the country, medical directors of skilled nursing and long-term care sites say they’ve been scrambling to obtain doses of the potent antibody therapies following a change in federal policy that critics say limits supplies for the vulnerable population of frail and elder residents who remain at highest risk of covid infection even after vaccination. (Read Full Article)